Clinical trial Recruiting at 1 site Interventional Ages 14 to 14 Women only

FACE-APPS approach to improve iron in adolescent girls in marginalized communities

Official title: FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities: A Randomized Control Trial

Run by Cairo University · NCT07633262 · Data updated 2026-11-12

This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.

Quick facts

Study typeInterventional
Ages14 Years to 14 Years
SexWomen only
Enrollment160 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Wadi Addawasir, Wadi Addawasir Governorate)
StatusRecruiting
StartedMay 24, 2026
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedJune 10, 2026
Trial IDNCT07633262 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescent females aged 14-17 years in selected high schools with hemoglobin <12 g/dL and ferritin <15 μg/L.

Probably not a fit

Girls without iron deficiency or with conditions that cause non-iron anemia may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled trial enrolling 160 female adolescents with low hemoglobin from seven secondary schools. Participants are randomly assigned to receive an eight‑week program of face‑to‑face counseling plus eight mobile app modules or standard care (diagnosis and referral). The primary outcomes are changes in hemoglobin and serum ferritin; secondary outcomes include engagement with the counseling sessions and app modules. The intervention is designed by an interdisciplinary team and implemented over four months in a school setting with digital health components grounded in health promotion principles. The study aims to address iron deficiency anemia in adolescent girls and evaluate whether a blended, school-based approach can yield meaningful hematologic improvements.

Why it matters

Potential benefit: If successful, the program could improve iron status and related health outcomes in adolescent girls, especially in underserved communities.

How similar studies have gone: Prior research supports school-based, multi-component approaches for improving iron status, though the FACE-APPS model is a targeted, blended method in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescent females aged 14-17 years
* who are attending high school
* who have haemoglobin levels \<12 mg/dl and serum ferritin levels below 15 μg/L

Exclusion Criteria:

* Adolescents have other causes of anemia, such as thalassemia and sickle cell anemia, and malaria will be excluded.
* Adolescents with chronic diseases that affect iron metabolism (e.g., chronic kidney disease) or other severe illnesses or conditions that may interfere with active participation.
* Pregnant females will be excluded (if included in the age group).
* Adolescents with gastrointestinal ulcers, colon polyps, or cancers; celiac disease; Crohn's disease; or gastric bypass surgery.

Where it's running

  • Administration of Education, Secondary Schools
    Wadi Addawasir, Wadi Addawasir Governorate, Saudi Arabia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.